Tram is an entrepreneurial non-executive director and former Fortune 50 C-level Executive with 28 years of leadership in technology-driven industries across five continents. Educated in Western and Anglo-Saxon environments, she has also nurtured a strong Asian cultural legacy that makes a difference in the boardroom. Sheis recognized for connecting the dots and bringing fresh international interdisciplinary collaboration and market expansion lenses powered by a diverse global network, governance, and market intelligence skills.
The breadth and depth of her experience come from having served in executive, advisory, and board leadership positions for varying-sized organizations, public and private, mid-sized family-owned businesses, and startups. As an inclusive leader, she has been interviewed and featured in four chapters of “The 5 Disciplines of Inclusive Leaders: Unleashing the Power of All of Us,” a book released by Korn Ferry in 2020.
Tram currently serves on a few public and private company boards, committed to advancing preventive healthcare with SaaS and deep technologies. She has also engaged as an Independent Director Affiliate member of the LPEA Luxembourg Private Equity Association adding governance insights to Private Equity-backed portfolio companies as well as continuously refreshing her directorship education with the PDA Private Directors Association and the NACD National Association of Corporate Directors.
As the founding chair of her private investment and acceleration holding Vitanlink, Tram has for the past 10 years, co-invested in pre-seed and supported SaaS and AI-driven companies as an advisor, board member and/or investor up to the post-seed and scaling stages in partnerships with accelerators, single family offices, VCs and PEs. She has consistently obtained a mentor rating of 9+ out of 10 from Endeavor Global Network of scale-ups CEOs.
.
PRIOR BOARD EXPERIENCE
Tram previously served as an executive member of the board of directors with an AI-powered wealth tech company. She was instrumental in recruiting a new CEO, repositioning the company from a B2B to a B2C AI product model, and led the company’s board decisions during the acquisition and transition into Synthetic Neural Labs Inc in 2021. She served as an independent lead board director for another emerging growth AI startup for the vision, where she helped the board connect to and acquire a Fortune100 listed US Group’s offer within 4 months
Tram added value as a member of the EMEA Executive Board for Welch Allyn Inc. mid-cap wholly owned by the Allyn family and since 2021 by Baxter International Inc (NYSE: BAX). She transformed the market, products, and channel models and closed an initial acquisition of the French entity by a European distributor that paved the way for future acquisitions.
Tram began her career as an auditor with EY, where she opened key offices in Vietnam and Cambodia before moving to J&J (NYSE: JNJ) Ortho-Clinic Diagnostics. She was awarded twice the Johnson & Johnson standards of leadership awards and she assumed increasing levels of P/L accountability, ultimately serving as a member of the EMEA management board. She expanded the international footprint for the $3 Billions JNJ’s IVD division.
Tram holds an MBA from McGill University, an active US Certified Public Accountant license [CPA New Hampshire State Board of Accounting], a certification in Private Company and Private Equity Portfolio Governance from the PDA, and the Financial Times Non-Executive Director Diploma.
